Graphic-output temperature data loggers for monitoring vaccine refrigeration: Implications for pertussis

American Journal of Public Health

Volumn 101, Issue 1, 2011, Pages 46-47

  McColloster, Patrick ^a   Vallbona, Carlos ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

ARTICLE; AUTOMATION; CHILD; CLINICAL TRIAL; EQUIPMENT; FREEZING; HEALTH CENTER; HUMAN; INCIDENCE; INSTRUMENTATION; MULTICENTER STUDY; PERTUSSIS; QUALITY CONTROL; UNITED STATES;

AUTOMATION; CHILD; COMMUNITY HEALTH CENTERS; EQUIPMENT FAILURE ANALYSIS; HUMANS; INCIDENCE; PERTUSSIS VACCINE; QUALITY CONTROL; REFRIGERATION; TEXAS; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 78650906764     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.179853     Document Type: Article

References (16)

1. Harris County Public Health and Environmental Services. 2007 Annual Report. Available at: http://www.hcphes.org/2007Annual.pdf. Accessed February 7, 2010.
2. Jajosky RA, Hall PA, Adams DA, et al. Summary of notifiable diseases - United States, 2004. MMWR Morb Mortal Wkly Rep. 2006;53(53):1-79.
3. O'Brien JA, Caro JJ. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis. 2005;5:57.
4. Milhomme P. Cold chain study: danger of freezing vaccines. Can Commun Dis Rep. 1993;19:33-38.
5. Ortega Molina P, Astasio AP, Albaladejo VR, et al. Vaccine storage cold chain at primary care centers in one area of Madrid: keeping the chain intact and degree of knowledge. Rev Esp Salud Publica. 2002;76(4):333-346.
6. Boros CA, Hanlon M, Gold MS, Roberton DM. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines. Vaccine. 2001;19(25-26): 3537-3542.
7. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007; 25(20):3980-3986.
8. Miller NC, Harris MF. Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory. Bull World Health Organ. 1994;72(3):401-408.
9. Gzyl A, Augustynowicz E, Rabczenko D. Potency of pertussis component in the DTP vaccine-an overview of a three decade study in Poland. Biologicals. 2004; 32(3):129-137.
10. Andreescu V, Marion M, Ivan I, et al. Influence of temperature on the stability of pertussis vaccine. Arch Roum Pathol Exp Microbiol. 1985;44(4):283-292.
11. Haworth EA, Booy R, Stirzaker L, Wilkes S, Battersby A. Is the cold chain for vaccines maintained in general practice? BMJ. 1993;307(6898):242-4.
12. Thakker Y, Woods S. Storage of vaccines in the community: weak link in the cold chain? BMJ. 1992; 304(6829):756-758.
13. Page SL, Earnest A, Birden H, et al. Improving vaccination cold chain in the general practice setting. Aust Fam Physician. 2008;37(10):892-896.
14. Gold MS, Martin L, Nayda CL, Kempe AE. Electronic temperature monitoring and feedback to correct adverse vaccine storage in general practice. Med J Aust. 1999; 171(2):83-84.
15. Vaccine Storage and Handling Toolkit. Atlanta, GA: Centers for Disease Control and Prevention; 2008.
16. Jacquet JM, Bégué P, Grimprel E, et al. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review. Vaccine. 2006;24(13):2440-2448.